Conrad Wai, CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 24,215 shares at $4.67 ($113K) on 2026-07-15, disclosed to the SEC on 2026-07-16.
Open-market sale of $113k CLOV by CEO, Counterpart Health. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLOV | SELL | 2025-07-24 | $996K | — | Filing → |
| CLOV | SELL | 2025-07-10 | $50K | — | Filing → |